Molecular genetics of Alport's syndrome
Flinter, F.
Quarterly Journal of Medicine 86(5): 289-292
1993
ISSN/ISBN: 0033-5622 PMID: 8327646 Document Number: 413428
Document emailed within 1 workday
Related Documents
Weber, M.; Netzer, K.O.; Pullig, O. 1994: New molecular biology findings in Alport syndrome Medizinische Klinik 89(4): 204-208Chen, N.; Pan, X.; Ren, H.; Dong, D. 1998: A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients Chinese Medical Journal 111(9): 797-802
Fukushima, Y. 1989: Chromosome and molecular genetics--molecular analysis of aniridia-Wilms' tumor syndrome Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 38-46
Albert, I.; Jais, J.P. 1999: Methodology for analyzing censored correlated data: application of marginal and frailty approaches in human genetics. The European Community Alport Syndrome Concerted Action Group (ECASCA) Revue d'Epidemiologie et de Sante Publique 47(6): 545-554
Garcia-Torres, R.; Cruz, D.; Orozco, L.; Heidet, L.; Gubler, M.C. 2000: Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. a synthesis Nephrologie 21(1): 9-12
Masternak, K.; Muhlethaler-Mottet, A.; Villard, J.; Peretti, M.; Reith, W. 2000: Molecular genetics of the Bare lymphocyte syndrome Reviews in Immunogenetics 2(2): 267-282
Damian, M.S.; Reichmann, H.; Seibel, P.; Bachmann, G.; Schachenmayr, W.; Dorndorf, W. 1994: MELAS syndrome. Clinical aspects, MRI, biochemistry and molecular genetics Der Nervenarzt 65(4): 258-263
Yoshida, K.; Yanagisawa, N. 1993: Molecular genetics of beta-galactosidase deficiency (GM1-gangliosidosis and Morquio syndrome type B) Nihon Rinsho. Japanese Journal of Clinical Medicine 51(9): 2269-2275
Al-Harbi, K.M.; Abdallah, A.M. 2016: LGMD2D syndrome: the importance of clinical and molecular genetics in patient and family management. Case Report Neuro Endocrinology Letters 37(4): 277-281
Fryns, J.P. 1995: Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general Genetic Counseling 6(4): 293-296
Pedersen, Søren.; Jensen, L.G.; Jensen, P.K.A. 2006: Molecular karyotyping. The Danish Society of Molecular Genetics Ugeskrift for laeger 168(12): 1232
Papajík, T.; Zadrazil, J.; Bachleda, P. 1993: Alport's syndrome Vnitrni Lekarstvi 39(11): 1102-1107
Koch, B. 1970: Alport's Syndrome Canadian Medical Association Journal 102(10): 1109
Schröder, C.H.; Monnens, L.A.; Veerkamp, J.H.; Brunner, H.G. 1988: Alport's syndrome Nederlands Tijdschrift Voor Geneeskunde 132(7): 289-293
Kashtan, C.E. 1997: Alport syndrome Kidney International. Supplement 58: S69-S71
Hejcmanová, D.; Peregrin, J.; Svĕrák, J.; Hartmann, M. 1992: Ocular changes in Alport's syndrome Ceskoslovenska Oftalmologie 48(1): 48-53
Weidauer, H.; Arnold, W. 1976: Morphological changes in the inner ear of alport's syndrome Laryngologie Rhinologie Otologie 55(1): 6-16
Hudgins, L.B.; Limbacher, J.P. 1982: Fibromuscular dysplasia in Alport's syndrome Journal of the Tennessee Medical Association 75(11): 733-735
Simon, P.; Tirel, F.; Tanquerel, T.; Toulet, R.; Ramee, M.P. 1977: Selective IgA deficiency in Alport's syndrome La Nouvelle Presse Medicale 6(42): 3980
Decock, C.; De Laey, J.J.; Leroy, B.P.; Kestelyn, P.H. 2003: Alport syndrome and conjunctival telangiectasia Bulletin de la Societe Belge d'Ophtalmologie 290: 29-31